1、Liu WT, Liu BY, Cai Q, Li JF, Chen XH, Zhu ZG.#. Proteomic identification of serum biomarkers for gastric cancer using multi-dimensional liquid chromatography and 2D differential gel electrophoresis.. Clin Chim Acta.,2012;413(13-14):1098-106.
2、Lei KF, Liu BY, Jin XL, Guo Y, Ye M, Zhu ZG.#. Prognostic value of nuclear maspin expression for adjuvant 5-fluorouracil-based chemotherapy in advanced gastric cancer.. Exp Ther Med.,2012;3(6):993-998.
3、Ke-Feng Lei, Bing-Ya Liu, Xiao-Qing Zhang, Xiao-Long Jin, Yan Guo, Min Ye, Zheng-Gang Zhu.#. Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors.. Exp Ther Med.,2012;3(1):109-116.
4、Zheng YN#, Chen L, Li JF, Yu BQ, Su LP, Chen XH, Yu YY, Yan M, Liu BY, Zhu ZG.. Hypermethylated DNA as potential biomarkers for gastric cancer diagnosis.. Clinical Biochemistry,2011;44:1405-11.
5、Li C#, Mei JW, Yan M, Chen MM, Yao XX, Yang QM, Zhou R, Zhu ZG.. Nasogastric Decompression for Radical Gastrectomy for Gastric Cancer: A Prospective Randomized Controlled Study.. Dig Surg.,2011;28(3):167-172.
6、Yao XX#, Sah BK, Yan M, Chen MM, Zhu ZG.. Radical gastrectomy with combined splenectomy: unnecessary.. Hepatogastroenterology.,2011;25(107-108):1067-70.
7、Jiang JL#, Liu W, Guo XB, Zhang R, Zhi Q, Zhang JN, Chen XH, Li J, Zhang J, Gu QL, Liu BY, Zhu ZG, Yu YY.. IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer.. Oncogene.,2011;30:4498-4508.
8、Feng RH#, Chen XH, Yu YY, Su LP, Yu BQ, Li JF, Cai Q, Yan M, Liu BY, Zhu ZG.. miR-126 functions as a tumour suppressor in human gastric cancer.. Cancer Letters,2010;298:50-63.
9、Li C#, Yan M, Chen J, Xiang M, Zhu ZG, Yin HR, Lin YZ. Survival benefit of non-curative gastrectomy for gastric cancer patients with synchronous distant metastasis. J Gastrointest Surg,2010;14(2):282-8
10、Yan C*, Zhu ZG, Yan M, Zhang H, Pan ZL, Chen J, Xiang M, Chen MM, Liu BY, Yin HR, Lin YZ.. Size of the largest lymph node visualized on multi-detector-row computed tomography (MDCT) is useful in predicting metastatic lymph node status of gastric cancer.. J Int Med Res.,2010;38(1):22-33.
11、Li C*, Yan M, Chen J, Xiang M, Zhu ZG, Yin HR, Lin YZ.. Surgical resection with hyperthermic intraperitoneal chemotherapy for gastric cancer patients with peritoneal dissemination.. J Surg Oncol.,2010;102(5):361-5.
12、Guo X*, Liu W, Pan Y, Ni P, Ji J, Guo L, Zhang J, Wu J, Jiang J, Cheng X, Cai Q, Li J, Zhang J, Gu Q, Liu B, Zhu Z, Yu Y.. Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma. Oncogene,2010;29(27):3908-20
13、Sah BK*, Chen MM, Yan M, Zhu ZG. Reoperation for early postoperative complications after gastric cancer surgery in a Chinese hospital. World J Gastroenterol,2010;16(1):98-103
14、Sah BK*, 陈明敏,燕敏,朱正纲. Gastric cancer surgery: Billroth I or Billroth II for distal gastrectomy?. BMC Cancer,2009;9:428-435
15、Sah BK*, Zhu ZG, Wang XY, Yang QM, Chen MM, Xiang M, Chen J, Yan M.. Post-operative complications of gastric cancer surgery: female gender at high risk.. Eur J Cancer Care (Engl),2009;18(2):202-8
16、Yan C*, Zhu ZG, Yan M, Zhang H, Pan ZL, Chen J, Xiang M, Chen MM, Liu BY, Yin HR, Lin YZ.. Value of multidetector-row computed tomography in the preoperative T and N staging of gastric carcinoma: a large-scale Chinese study.. J Surg Oncol,2009;100(3):205-14
17、Li C*, Yan M, Chen J, Xiang M, Zhu ZG, Lin YZ. Prognostic influence of sub-stages according to pTNM categories in patients with stage IV gastric cancer. J Surg Oncol,2009;99:324-328
18、Sah BK*, Zhu ZG, Chen MM, Xiang M, Chen J, Yan M, Lin YZ. Effect of surgical work volume on postoperative complication: superiority of specialized center in gastric cancer treatment. Langenbecks Arch Surg,2009;394(1):41-7
19、Birendra KS*, Chen MM, Peng YB, Feng XJ, Yan M, Liu By, Fan QS, Zhu ZG.. Does testosterone prevent early postoperative complications after gastrointestinal surgery?. World J Gastroenterol,2009;15(44):5604-5609
20、Hao Y#, Yu Y, Wang L, Yan M, Ji J, Qu Y, Zhang J, Liu B, Zhu Z*. IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology. . J Proteome Res.,2008;7(9):3668-77
21、Liu W#, Liu B, Xin L, Zhang Y, Chen X, Zhu Z*, Lin Y.. Down-regulated expression of complement factor I: A potential suppressive protein for gastric cancer identified by serum proteome analysis.. Clin Chim Acta.,2007;377(1-2):119-26.
22、Wang YW#, Qu Y, Li JF, Chen XH, Liu BY, Gu QL, Zhu ZG*.. In vitro and in vivo evidence of metallopanstimulin-1 in gastric cancer progression and tumorigenicity.. Clin Cancer Res.,2006;12(16):4965-73
|
